Navigation Links
Western Pain Society Galvanizes Coalition to Launch the Alliance for Rational Use of NSAIDs
Date:9/6/2012

LAS VEGAS, Sept. 6, 2012 /PRNewswire/ -- To coincide with PAINWeek 2012, the Western Pain Society, the largest regional society of the American Pain Society, in partnership with eight professional and patient organizations, announced today the launch of the Alliance for Rational Use of NSAIDs. The Alliance will serve as a public health coalition of professional and patient organizations, clinicians and other relevant stakeholders committed to supporting the safe and appropriate use of nonsteroidal anti-inflammatory drugs (NSAIDs).

(Logo:  http://photos.prnewswire.com/prnh/20120906/NY69248LOGO-a  )

(Photo: http://photos.prnewswire.com/prnh/20120906/NY69248-INFO-b )

The Alliance is organized under the auspices of the Western Pain Society in partnership with:

  • American Academy of Nurse Practitioners
  • American Academy of Physician Assistants
  • American Association of Colleges of Pharmacy
  • American Chronic Pain Association
  • HealthyWomen
  • National Council on Patient Information and Education
  • National Kidney Foundation

NSAIDs are one of the most commonly used medications in the United States for pain relief and reduction of fever and inflammation. NSAIDs, available by prescription and sold over-the-counter (OTC) by brand and generic names, such as ibuprofen or naproxen, are generally safe when used properly. However, as with all medications, NSAIDs are not without risks and can cause significant and even life-threatening adverse events that affect gastrointestinal (digestive system), renal (kidney) and cardiovascular (heart) health.

To guide appropriate use and lessen the risk of adverse events, the FDA and medical societies strongly recommend that all NSAIDs should be administered at the lowest effective dose for the shortest duration of time, while taking into account patient-specific risk factors and clinical needs. However, implementation of this guidance is lacking and the Alliance for Rational Use of NSAIDs aims to change that.

"Failure to comply with NSAID medical guidance is common, but taking NSAIDs inappropriately can pose major health risks for those managing pain and inflammation," said Dr. Bill McCarberg, president of the Western Pain Society and Chair of the Alliance for Rational NSAID Use. "As NSAID use continues to grow in an aging America, we hope to bridge the gap between the medical guidance and real-world use of NSAIDs."

The availability and use of OTC NSAIDs complicates adherence to guidance and impacts the safe use of NSAID products. In an observational study of osteoarthritis patients, over 90 percent of patients were at increased gastrointestinal or cardiovascular risk, but more than half of those patients were prescribed OTC NSAIDs not in accordance with current guidelines or regulatory recommendations.

"There is a desperate need for education and active communication about safe use of NSAIDs with health care professionals, as well as within the patient community," said Jennifer Wagner, executive director of the Western Pain Society. "Our hope is that the Alliance will bring this initiative to life and make a difference for patients requiring the use of NSAID therapy."

While driving appropriate use of NSAIDs is imperative to prevent greater public health concerns, the Alliance recognizes the value NSAIDs serve in the pain community. Fear of side effects should not prevent people from taking NSAIDs, since untreated pain can become a serious health issue as well. Instead, it is important to be attentive to ensure that those taking NSAIDs are taking the lowest dose for the shortest duration of time.

For more information about the Alliance for Rational Use of NSAIDs, or to become an Alliance partner, visit: www.NSAIDAlliance.com. Follow us on Twitter at @NSAIDAware,  www.twitter.com/NSAIDAware.

About the Alliance for Rational Use of NSAIDs
The Alliance for Rational Use of NSAIDs is a public health coalition dedicated to the safe and appropriate use of nonsteroidal anti-inflammatory drugs (NSAIDs). The Alliance aims to bridge the gap between guidance and clinical practice, educating health care professionals and the public at-large on the and appropriate use of NSAID therapy—maximizing benefits while reducing risks, and improving health care delivery. To learn more or to get involved, visit www.NSAIDAlliance.com.


'/>"/>
SOURCE Alliance for Rational Use of NSAIDs
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Outlook for Medical Devices in Western Europe
2. Millennium Laboratories Angela Huskey Named Industry Pain Educator of the Year by American Society of Pain Educators
3. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
4. Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
5. The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain
6. Henry Schein Chairman and CEO Stanley M. Bergman Honored By Hispanic Dental Association, National Dental Association and Society of American Indian Dentists
7. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
8. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
9. Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society
10. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
11. European Hematology Association, American Society of Hematology, and the European Cancer Patient Coalition Issue an International Call to Action to Alleviate Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/26/2017)... NEW YORK , July 26, 2017 ... Annual Prix Galien USA Award ... honors, the Prix Galien Award recognizes outstanding biomedical and technology ... To qualify, each candidate must be ... the last five years and demonstrate tremendous potential to impact ...
(Date:7/24/2017)... 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... second quarter 2017 operating results on Monday, August 7, ... follow at 5:00 p.m. ET. ... a live broadcast of the conference call by dialing ... code 51641230 approximately 15 minutes prior to the call. ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... An inventor from Salisbury, N.C., ... haven’t yet seen an effective and dignified way to keep leeches in place during ... CUP." , This invention provides an effective way to keep a leech in place ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs ... freeze drying samples and a lengthy freeze dry cycle are a few common challenges ... drying techniques, as well as new accessories and advancements in laboratory freeze dryers that ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... the cloud ; today announced the availability of its latest data protection solution ... use control console for Data Discovery, Classification, Encryption and Digital Rights Management; GTB ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and ... from April 1, 2017 to June 30, 2017. Iso International LLC recorded unaudited ...
(Date:7/25/2017)... St. Louis, MO (PRWEB) , ... July 25, 2017 , ... ... (HDIS) in St. Louis, Missouri. The company has achieved record-breaking sales for ... multiple departments over the next 12 months. , The upcoming year offers excitement and ...
Breaking Medicine News(10 mins):